Otsuka Holdings Co., Ltd.

Equities

4578

JP3188220002

Delayed Japan Exchange Other stock markets 06:30:00 13/03/2026 GMT			5-day change	1st Jan Change
11,005.00 ^JPY	-0.14%		+9.39%	+24.03%

03-04	Irlab Working to Secure Funding for Phase 3 Study of Mesdopetam - fc	FW
02-26	Irlab Receives $3 Million Milestone Payment Following Dosing in Phase 1b Study	FW

Transcript : Otsuka Holdings Co., Ltd., 2025 Earnings Call, Feb 13, 2026

Published on 02/14/2026 at 05:06 pm GMT

S&P Capital IQ

Presenter Speech
Makoto Inoue (Executives)

Thank you for taking time to join Otsuka Holdings financial results briefing today. I am Inoue, President and CEO. Before getting into the details of our FY

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Otsuka Holdings Co., Ltd.

03-04	Irlab Working to Secure Funding for Phase 3 Study of Mesdopetam - fc	FW
02-26	Irlab Receives $3 Million Milestone Payment Following Dosing in Phase 1b Study	FW
02-14	Otsuka Holdings Co., Ltd., 2025 Earnings Call, Feb 13, 2026
02-13	Otsuka Holdings Co., Ltd. Announces Dividend for the Fiscal Year Ended December 31, 2025, Payable on March 30, 2026	CI
02-13	Otsuka Holdings Co., Ltd. Provides Earnings Guidance for the Second Quarter (Year to Date) and for the Year Ending December 31, 2026	CI
02-13	Otsuka Holdings Co., Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal 2026 and Year Ending December 31, 2026	CI
02-13	Otsuka Holdings Co., Ltd. authorizes a Buyback Plan.	CI
02-13	Otsuka Holdings Co., Ltd. announces an Equity Buyback for 7,000,000 shares, representing 1.33% for ¥50,000 million.	CI
02-13	Japan Stocks End Week in Red As BOJ Hawk Flags Near-Term Rate Rise	MT
02-13	Otsuka Holdings Co Ltd to buy back up to 1.33% of own shares worth 50 billion yen	RE
02-13	Otsuka Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-13	Otsuka's Profit Climbs 20% in 2025	MT
02-04	Biodexa announces exclusive license of Otsuka's OPB-171775, a potent phase 1 ready molecular glue for GIST	RE
02-04	HBM Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2025	CI
02-02	Otsuka Corporation Provides Dividend Guidance for the Second Quarter End of Fiscal Year Ending March 31, 2026	CI